Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,963 | 245 | 99.5% |
| Education | $31.59 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,152 | 46 | $0 (2023) |
| AbbVie Inc. | $856.04 | 39 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $524.00 | 18 | $0 (2024) |
| Galderma Laboratories, L.P. | $488.90 | 10 | $0 (2024) |
| GENZYME CORPORATION | $443.42 | 9 | $0 (2024) |
| Dermavant Sciences, Inc. | $334.18 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $324.25 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $298.89 | 15 | $0 (2024) |
| Celgene Corporation | $290.11 | 9 | $0 (2019) |
| Incyte Corporation | $242.10 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,095 | 39 | Regeneron Healthcare Solutions, Inc. ($303.97) |
| 2023 | $1,408 | 45 | PFIZER INC. ($270.32) |
| 2022 | $691.29 | 24 | ABBVIE INC. ($165.25) |
| 2021 | $80.35 | 3 | PFIZER INC. ($35.87) |
| 2020 | $112.11 | 6 | PFIZER INC. ($42.95) |
| 2019 | $1,322 | 53 | AbbVie, Inc. ($255.15) |
| 2018 | $1,018 | 35 | PFIZER INC. ($316.52) |
| 2017 | $1,268 | 42 | Galderma Laboratories, L.P. ($276.12) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $35.29 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.93 | General |
| Category: Immunology | ||||||
| 09/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Dermatology | ||||||
| 08/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $125.12 | General |
| Category: DERMATOLOGY | ||||||
| 08/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: DERMATOLOGY | ||||||
| 07/31/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation | ||||||
| 07/19/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: DERMATOLOGY | ||||||
| 07/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Inflammation | ||||||
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,757 | 7,818 | $576,993 | $335,789 |
| 2022 | 27 | 3,970 | 8,310 | $657,315 | $390,308 |
| 2021 | 25 | 3,602 | 7,782 | $592,095 | $366,701 |
| 2020 | 24 | 3,362 | 7,630 | $535,820 | $325,336 |
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 552 | 747 | $98,591 | $67,147 | 68.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 614 | 925 | $94,560 | $59,658 | 63.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 449 | 826 | $87,809 | $50,301 | 57.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 298 | 345 | $41,653 | $21,329 | 51.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 496 | 703 | $68,574 | $21,160 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 192 | $27,638 | $17,741 | 64.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 375 | 2,610 | $21,855 | $13,932 | 63.7% |
| 67850 | Destruction of growth of eyelid margin, 1.0 cm or less | Office | 2023 | 57 | 60 | $15,144 | $11,436 | 75.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 137 | 137 | $17,055 | $10,579 | 62.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 25 | $12,568 | $9,241 | 73.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 24 | 26 | $12,396 | $8,868 | 71.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $14,218 | $8,026 | 56.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 40 | 43 | $8,792 | $5,852 | 66.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 74 | 109 | $7,217 | $4,845 | 67.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 110 | $7,289 | $4,677 | 64.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $7,332 | $4,584 | 62.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 35 | 39 | $10,934 | $3,950 | 36.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 34 | 34 | $4,959 | $3,142 | 63.4% |
| 67810 | Biopsy of eyelid | Office | 2023 | 18 | 18 | $4,513 | $2,354 | 52.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 47 | 59 | $3,991 | $1,806 | 45.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 16 | $2,472 | $1,678 | 67.9% |
| 69100 | Biopsy of ear | Office | 2023 | 20 | 23 | $2,771 | $1,133 | 40.9% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 16 | 22 | $1,818 | $1,065 | 58.6% |
| 11000 | Removal of inflamed or infected skin, up to 10% of body surface | Office | 2023 | 24 | 25 | $1,564 | $811.45 | 51.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 58 | 636 | $1,280 | $472.98 | 36.9% |
About Dr. William Wickwire, MD
Dr. William Wickwire, MD is a Dermatology healthcare provider based in Redondo Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699779660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Wickwire, MD has received a total of $6,994 in payments from pharmaceutical and medical device companies, with $1,095 received in 2024. These payments were reported across 247 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,963).
As a Medicare-enrolled provider, Wickwire has provided services to 14,691 Medicare beneficiaries, totaling 31,540 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Redondo Beach, CA
- Active Since 06/08/2005
- Last Updated 02/21/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699779660
Products in Payments
- EUCRISA (Drug) $775.64
- DUPIXENT (Biological) $518.89
- Otezla (Drug) $468.59
- Humira (Biological) $431.14
- VTAMA (Drug) $334.18
- LIBTAYO (Biological) $311.16
- SOOLANTRA (Drug) $298.31
- COSENTYX (Biological) $283.09
- OPZELURA (Drug) $242.10
- DUPIXENT (Drug) $231.93
- SKYRIZI (Biological) $208.14
- TREMFYA (Drug) $205.98
- SILIQ (Drug) $173.82
- TALTZ (Drug) $170.24
- Cimzia (Drug) $145.59
- ADBRY (Biological) $130.35
- ORACEA (Drug) $95.48
- CIBINQO (Drug) $90.99
- Skyrizi (Biological) $83.24
- LITFULO (Drug) $81.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Redondo Beach
Annie Chiu, Md, MD
Dermatology — Payments: $308,147
Geover Fernandez, Md, MD
Dermatology — Payments: $14,791
Dr. Neal Ammar, M.d, M.D
Dermatology — Payments: $4,534
Anabella Pascucci, M.d, M.D
Dermatology — Payments: $323.59
Dr. Sanusi Umar, M.d, M.D
Dermatology — Payments: $112.16